Interestingly, the genetic ablation of HDAC11 is associated with a heightened level of T cell activation (19), offering the possibility that, similar to agents of the IMiD class, HDAC11 inhibition may also enhance anti-MM T cell immune responses. This evidence concerns the gene HDAC11 and Miyoshi myopathy.